Netherlands· NL-b05bc86ef2a8
Mycofenolaatmofetil Accord 500 mg poeder voor concentraat voor oplossing voor infusie
A mycophenolic acid product containing mycofenolaatmofetil, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Mycophenolic acid is registered in 15 of 19 countries.
Countries holding a registration under ATC L04AA06 (mycophenolic acid), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Mycophenolic acid · ATC L04AA06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mycophenolic acid costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mycophenolic acid · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.57
- IT Italy$8.14
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MYCOFENOLAATMOFETIL
- Manufacturer
- Accord Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- L04AA06
- ATC class
- Mycophenolic acid
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id115229
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
350 interactions on record for mycophenolic acid.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mycophenolic acid · interactions on record
350 records
- 50 severe
- 179 moderate
- 20 minor
- 75 info
Most severe, free to view
- Medicinal charcoalA07BA01severe
- ColestyramineC10AC01severe
- ColestipolC10AC02severe
- ColesevelamC10AC04severe
26 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mycophenolic acid in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceCELLCEPT 500 mg, poudre pour solution à diluer pour perfusionROCHE REGISTRATION (ALLEMAGNE)
- SwitzerlandCellcept
- PolandCellCeptRoche Registration GmbH
- IcelandCellceptRoche Registration GmbH*
- CanadaAPO-MYCOPHENOLIC ACIDAPOTEX INC
- SwedenMyfortic 180 mg EnterotablettEbb Medical AB
- ItalyACIDO MICOFENOLICO ACCORDACCORD HEALTHCARE B.V.
- United KingdomCeptava 180mg gastro-resistant tabletsSandoz Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Mycophenolsäure Accord, Myfortic
- Belgium · Myfortic
- Bulgaria · Mифортик
- Cyprus · Myfortic
- Czechia · Mycophenolic Acid Accord, Myfortic
- Germany · Mycophenolat Mofetil Accord, Mycophenolatmofetil Heumann
- Denmark · Myastad, Mycophenolsyre Accord
- Estonia · Myfortic
- Spain · Ácido Micofenólico Stada, Myfortic
- Finland · Myastad, Myfortic
- France · Acide Mycophenolique Tillomed, Myfortic
- United Kingdom (Northern Ireland) · Mycophenolic Acid Accord Healthcare, Myfortic
- Greece · Myfortic
- Croatia · Mikofenolatna Kiselina Accord, Myfortic
- Hungary · Mikofenolsav Tillomed, Myfortic
- Ireland · Myfortic
- Iceland · Mycofenolsýra Accord, Myfortic
- Italy · Acido Micofenolico Accord, Acido Micofenolico Tillomed
- Lithuania · Myfortic
- Luxembourg · Myfortic
- Latvia · Myfortic
- Malta · Myfortic
- Norway · Myfortic, Mykofenolsyre Accord
- Poland · Marelim, Myfortic
- Portugal · Ácido Micofenólico Accord, Ácido Micofenólico Tillomed
- Romania · Myfortic
- Sweden · Myfortic, Mykofenolsyra Accord
- Slovenia · Myfortic
- Slovakia · Myfortic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/02bd6062-702d-40c2-aa01-96e7d75d6672 GET /v1/drugs/02bd6062-702d-40c2-aa01-96e7d75d6672?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h115229_smpc.pdf",
"strength": null,
"atc_label": "Mycophenolic Acid",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg115229",
"excipients": [
"CITROENZUUR 0-WATER (E 330)",
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"POLYSORBAAT 80 (E 433)",
"STIKSTOF (HEAD SPACE) (E 941)",
"ZOUTZUUR (E 507)"
],
"substances": [
"MYCOFENOLAATMOFETIL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h115229.pdf",
"authorised_at": "2015/04/20",
"procedure_number": "NL/H/4568/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "115229",
"additional_monitoring": "N"
}See everything about mycophenolic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.